Ernexa Therapeutics
(NASDAQ) ERNA
Ernexa Therapeutics Financials at a Glance
Market Cap
$7.87M
Revenue (TTM)
$0.00
Net Income (TTM)
$14.08M
EPS (TTM)
$-3.26
P/E Ratio
-0.08
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$0.27
Volume
25,536
Open
$0.28
Price
$0.27
Volume
25,536
Open
$0.28
Previous Close
$0.27
Daily Range
$0.26 - $0.29
52-Week Range
$0.26 - $4.05
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$0.27
Volume
25,536
Open
$0.28
Previous Close
$0.27
Daily Range
$0.26 - $0.29
52-Week Range
$0.26 - $4.05
ERNA News
ERNA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ernexa Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
Sanjeev Luther, MBA
Website
www.ernexatx.comHeadquarters
Cambridge, MA 92121, US
ERNA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-687%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
-12.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.87M
Shares Outstanding
29.15M
Volume
25.54K
Short Interest
0.00%
Avg. Volume
1.60M
Financials (TTM)
Gross Profit
$263.00K
Operating Income
$9.32M
EBITDA
$9.06M
Operating Cash Flow
$7.02M
Capital Expenditure
$37.00K
Free Cash Flow
$7.05M
Cash & ST Invst.
$1.88M
Total Debt
$490.00K
Ernexa Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$69.00K
-7000.0%
Gross Margin
0.00%
N/A
Market Cap
$7.87M
N/A
Market Cap/Employee
$1.31M
N/A
Employees
6
N/A
Net Income
$1.50M
+73.9%
EBITDA
$2.02M
+7.8%
Quarterly Fundamentals
Net Cash
$1.39M
+33.4%
Accounts Receivable
$95.00K
-78.3%
Inventory
$0.00
N/A
Long Term Debt
$277.00K
-41.9%
Short Term Debt
$213.00K
+2.9%
Return on Assets
-2.41%
N/A
Return on Invested Capital
-3.42%
N/A
Free Cash Flow
$1.16M
+67.2%
Operating Cash Flow
$1.15M
+67.6%